SPHINGOGLYCOLIPID ANALOGUES AS THERAPEUTIC AGENTS
This invention relates to sphingoglycolipid analogues of formula CN145: OH CN145 HO < - 0 n r 0 0 tail N Ci5115,4= compositions comprising these compounds, processes for preparing the compounds, and methods of treating or preventing diseases or conditions using the compounds, such as diseases or...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | HERMANS, IAN FRANCIS ANDERSON, REGAN JAMES LARSEN, DAVID SAMUEL HAYMAN, COLIN MALCOLM COMPTON, BENJAMIN JASON PAINTER, GAVIN FRANK |
description | This invention relates to sphingoglycolipid analogues of formula CN145: OH CN145 HO < - 0 n r 0 0 tail N Ci5115,4= compositions comprising these compounds, processes for preparing the compounds, and methods of treating or preventing diseases or conditions using the compounds, such as diseases or conditions relating to infection, atopic disorders, autoimmune disease, diabetes or cancer. Date Recue/Date Received 2020-06-05
La présente invention concerne des analogues de glycosphingolipide, des compositions comprenant ces composés, des procédés de préparation des composés, et des méthodes de traitement ou de prévention de maladies ou d'états faisant intervenir ces composés, tels que des maladies ou des états associés à une infection, des troubles atopiques, une maladie auto-immune, un diabète ou un cancer. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2880191C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2880191C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2880191C3</originalsourceid><addsrcrecordid>eNrjZDAMDvDw9HP3d_eJdPb38QzwdFFw9HP08XcPdQ1WcAxWCPFwDXIMcA0N8XRWcHR39QsJ5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8c6ORhYWBoaWhs7GhFUAAOCeJfM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SPHINGOGLYCOLIPID ANALOGUES AS THERAPEUTIC AGENTS</title><source>esp@cenet</source><creator>HERMANS, IAN FRANCIS ; ANDERSON, REGAN JAMES ; LARSEN, DAVID SAMUEL ; HAYMAN, COLIN MALCOLM ; COMPTON, BENJAMIN JASON ; PAINTER, GAVIN FRANK</creator><creatorcontrib>HERMANS, IAN FRANCIS ; ANDERSON, REGAN JAMES ; LARSEN, DAVID SAMUEL ; HAYMAN, COLIN MALCOLM ; COMPTON, BENJAMIN JASON ; PAINTER, GAVIN FRANK</creatorcontrib><description>This invention relates to sphingoglycolipid analogues of formula CN145: OH CN145 HO < - 0 n r 0 0 tail N Ci5115,4= compositions comprising these compounds, processes for preparing the compounds, and methods of treating or preventing diseases or conditions using the compounds, such as diseases or conditions relating to infection, atopic disorders, autoimmune disease, diabetes or cancer. Date Recue/Date Received 2020-06-05
La présente invention concerne des analogues de glycosphingolipide, des compositions comprenant ces composés, des procédés de préparation des composés, et des méthodes de traitement ou de prévention de maladies ou d'états faisant intervenir ces composés, tels que des maladies ou des états associés à une infection, des troubles atopiques, une maladie auto-immune, un diabète ou un cancer.</description><language>eng ; fre</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SUGARS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210420&DB=EPODOC&CC=CA&NR=2880191C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210420&DB=EPODOC&CC=CA&NR=2880191C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HERMANS, IAN FRANCIS</creatorcontrib><creatorcontrib>ANDERSON, REGAN JAMES</creatorcontrib><creatorcontrib>LARSEN, DAVID SAMUEL</creatorcontrib><creatorcontrib>HAYMAN, COLIN MALCOLM</creatorcontrib><creatorcontrib>COMPTON, BENJAMIN JASON</creatorcontrib><creatorcontrib>PAINTER, GAVIN FRANK</creatorcontrib><title>SPHINGOGLYCOLIPID ANALOGUES AS THERAPEUTIC AGENTS</title><description>This invention relates to sphingoglycolipid analogues of formula CN145: OH CN145 HO < - 0 n r 0 0 tail N Ci5115,4= compositions comprising these compounds, processes for preparing the compounds, and methods of treating or preventing diseases or conditions using the compounds, such as diseases or conditions relating to infection, atopic disorders, autoimmune disease, diabetes or cancer. Date Recue/Date Received 2020-06-05
La présente invention concerne des analogues de glycosphingolipide, des compositions comprenant ces composés, des procédés de préparation des composés, et des méthodes de traitement ou de prévention de maladies ou d'états faisant intervenir ces composés, tels que des maladies ou des états associés à une infection, des troubles atopiques, une maladie auto-immune, un diabète ou un cancer.</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAMDvDw9HP3d_eJdPb38QzwdFFw9HP08XcPdQ1WcAxWCPFwDXIMcA0N8XRWcHR39QsJ5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8c6ORhYWBoaWhs7GhFUAAOCeJfM</recordid><startdate>20210420</startdate><enddate>20210420</enddate><creator>HERMANS, IAN FRANCIS</creator><creator>ANDERSON, REGAN JAMES</creator><creator>LARSEN, DAVID SAMUEL</creator><creator>HAYMAN, COLIN MALCOLM</creator><creator>COMPTON, BENJAMIN JASON</creator><creator>PAINTER, GAVIN FRANK</creator><scope>EVB</scope></search><sort><creationdate>20210420</creationdate><title>SPHINGOGLYCOLIPID ANALOGUES AS THERAPEUTIC AGENTS</title><author>HERMANS, IAN FRANCIS ; ANDERSON, REGAN JAMES ; LARSEN, DAVID SAMUEL ; HAYMAN, COLIN MALCOLM ; COMPTON, BENJAMIN JASON ; PAINTER, GAVIN FRANK</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2880191C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>HERMANS, IAN FRANCIS</creatorcontrib><creatorcontrib>ANDERSON, REGAN JAMES</creatorcontrib><creatorcontrib>LARSEN, DAVID SAMUEL</creatorcontrib><creatorcontrib>HAYMAN, COLIN MALCOLM</creatorcontrib><creatorcontrib>COMPTON, BENJAMIN JASON</creatorcontrib><creatorcontrib>PAINTER, GAVIN FRANK</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HERMANS, IAN FRANCIS</au><au>ANDERSON, REGAN JAMES</au><au>LARSEN, DAVID SAMUEL</au><au>HAYMAN, COLIN MALCOLM</au><au>COMPTON, BENJAMIN JASON</au><au>PAINTER, GAVIN FRANK</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SPHINGOGLYCOLIPID ANALOGUES AS THERAPEUTIC AGENTS</title><date>2021-04-20</date><risdate>2021</risdate><abstract>This invention relates to sphingoglycolipid analogues of formula CN145: OH CN145 HO < - 0 n r 0 0 tail N Ci5115,4= compositions comprising these compounds, processes for preparing the compounds, and methods of treating or preventing diseases or conditions using the compounds, such as diseases or conditions relating to infection, atopic disorders, autoimmune disease, diabetes or cancer. Date Recue/Date Received 2020-06-05
La présente invention concerne des analogues de glycosphingolipide, des compositions comprenant ces composés, des procédés de préparation des composés, et des méthodes de traitement ou de prévention de maladies ou d'états faisant intervenir ces composés, tels que des maladies ou des états associés à une infection, des troubles atopiques, une maladie auto-immune, un diabète ou un cancer.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre |
recordid | cdi_epo_espacenet_CA2880191C |
source | esp@cenet |
subjects | CHEMISTRY DERIVATIVES THEREOF HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS |
title | SPHINGOGLYCOLIPID ANALOGUES AS THERAPEUTIC AGENTS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T23%3A13%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HERMANS,%20IAN%20FRANCIS&rft.date=2021-04-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2880191C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |